Search results for

The launch of a venture-backed new women's site was complicated by its founder's claims that it was "different" and that as CEO, "knowing the difference between mascara, concealer, and eye-liner is not my job."

Teams haven't typically tried to develop knuckleballers and players haven't usually wanted to throw the pitch. But now the Baltimore Orioles are teaching the knuckleball to three minor league pitchers. A physics expert and fan of the pitch wonders whether this could be the start of a "knuckleball era."

At the farmers market this time of year, tomatoes are strutting their stuff in all sorts of glorious and quirky colors: green striped, white, pink, purplish-brown. Consumers have seed savers and amateur breeders to thank for discovering and sharing some of these heirloom varieties, like the Cherokee Purple.

After suffering dozens of attacks against staff members, including kidnappings and murders, the nonprofit is closing all operations in Somalia. In many parts of the country, the aid group was the only source of health care.

Jackson pleaded guilty to using more than $750,000 from his campaign fund for personal purchases, including a Rolex watch, furniture and fur capes and parkas.

Born in Nigeria, Chinelo Okparanta was raised in the U.S. by her parents who were Jehovah's Witnesses. She talks to guest host Celeste Headlee about writing the truth about her home country, even if it's an ugly truth.

The state news agency said Nick Symmonds became the first athlete to criticize Russia's controversial anti-gay law. Symmonds said he believed every human "deserves equality."

Rose George spent several weeks aboard a container ship to research Ninety Percent of Everything, her book about the shipping industry. She writes, "There are more than one hundred thousand ships at sea carrying all the solids, liquids and gases that we need to live."

Some GOP lawmakers want to block all money for Obamacare in a stopgap spending bill that must be approved next month to prevent the government from shutting down on Oct. 1. But other Republicans say that won't work and may well backfire.

Doctors have debated for years whether a drug that curbed the growth of some prostate cancers caused more serious ones to grow faster. Now, a long-term study calms those fears and raises the possibility that a cheap, generic pill could be used reduce prostate cancer risk.